Nicholas Valiante
Seminars
Chair’s Opening Remarks
8:15 am
CXOs’ Panel Discussion: Unlocking the Next Frontiers of mRNA-Based Vaccines & Therapeutics to Ensure Better Drugs Reach Patients Faster
8:30 am
- What do you think are the top 3 opportunities/near future wins for the mRNA field?
- Given your role in the C-suite, what are the biggest challenges you face on a day-to-day basis and what kind of decisions do you have to make?
- Given your role and affiliation, how do you view the market consolidation and how does it affect your day-to-day and decision making?
- What are your views on the investor climate and partnership strategies or opportunities for collaboration in the mRNA field this year?
Thursday 2nd January 2025
Innovac’s End-To-End Approach to Capitalize on the mRNA Revolution in the Vaccine Industry
12:15 pm
- Describing Innovac’s platform technologies and pipeline to drive the next wave of therapeutic and prophylactic mRNA vaccines
- Selecting and stratifying disease targets and patient populations for mRNA vaccines
- Revealing new pre-clinical data from multiple vaccine projects targeting infectious diseases and cancer
